The Funding Statement for this article [1, 2] states that the study received funding from the Smoking Research Foundation, which according to [3] has received financial support from the tobacco industry. In light of this issue the PLOS ONE article [1, 2] does not comply with the journal’s policy on Funding from Tobacco Companies [4] which was implemented in 2010.
Therefore, the PLOS ONE Editors issue this Expression of Concern.
We regret that this concern was not identified and addressed prior to the article’s [1, 2] publication.
References
- 1.Wang S, Yabuki Y, Matsuo K, Xu J, Izumi H, Sakimura K, et al. (2018) T-type calcium channel enhancer SAK3 promotes dopamine and serotonin releases in the hippocampus in naive and amyloid precursor protein knock-in mice. PLoS ONE 13(12): e0206986. 10.1371/journal.pone.0206986 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Wang S, Yabuki Y, Matsuo K, Xu J, Izumi H, Sakimura K, et al. (2019) Correction: T-type calcium channel enhancer SAK3 promotes dopamine and serotonin releases in the hippocampus in naive and amyloid precursor protein knock-in mice. PLoS ONE 14(1): e0211590. 10.1371/journal.pone.0211590 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Iida K, Proctor RN. (2018) ‘The industry must be inconspicuous’: Japan Tobacco’s corruption of science and health policy via the Smoking Research Foundation. Tobacco Control 27:e3–e11. doi: 10.1136/tobaccocontrol-2017-053971 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.https://journals.plos.org/plosone/s/disclosure-of-funding-sources#loc-funding-from-tobacco-companies